Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

Cardinal Health's Shares Fall as Inflation and Supply Chain Constraints Hit Q3 Earnings

  • Cardinal Health Inc (NYSE:CAH) has reported Q3 FY22 adjusted EPS of $1.45, down 5% Y/Y, missing the consensus of $1.52
  • Q2 sales increased 14% Y/Y to $44.8 billion, beating the consensus estimate of $43.16 billion.
  • The pharmaceutical segment increased 17% to $41 billion, driven primarily by branded pharmaceutical sales growth from large Pharmaceutical Distribution and Specialty customers.
  • The medical segment sales decreased 7% to $3.9 billion due to the divestiture of the Cordis business and lower products and distribution volumes, which includes the impact of global supply chain constraints.
  • Related: Washington, Drug Distributors Reach $518M Settlement For Opioid Claims.
  • Outlook: For FY22, Cardinal Health revised adjusted EPS guidance to $5.15 - $5.25 from the previous guidance of $5.15 - $5.50, compared to the consensus of $5.29.
  • The company also updated the Medical segment profit outlook to a 45% - 55% decline, from 30% - 45%. The outlook includes a year-over-year net incremental headwind of nearly $300 million due to inflationary and global supply chain constraint impacts.
  • Price Action: CAH shares are down 3.75% at $58.22 on the last check Thursday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.